The ARTEMIS Data Collection Study
NCT07075861 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2025-12-24
Summary
To observe the safety and effectiveness of the JenaValve Trilogy™ Heart Valve System for transcatheter aortic valve replacement (TAVR) in subjects with evere native aortic regurgitation (AR) who are indicated for TAVR Data collection
Conditions
- Aortic Regurgitation Disease
Sponsors & Collaborators
-
IRCCS Policlinico S. Donato
lead OTHER
Principal Investigators
-
Luca Testa, PI · IRCCS Policlinico San Donato (San Donato Milanese) - IT
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-10
- Primary Completion
- 2028-08-10
- Completion
- 2028-08-10
Countries
- Italy
Study Locations
More Related Trials
-
A Clinical and Imaging Registry of Transcatheter Aortic Valve Implantation Using JenaValve System/ J-Valve System for Patients With Pure Aortic Regurgitation
NCT07021612 ·Status: RECRUITING
-
Screening for Amyloidosis Before Aortic Valve Elective Replacement
NCT04869631 ·Status: ACTIVE_NOT_RECRUITING
-
TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System
NCT07334691 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Transcatheter Artificial Aortic Valve and Transcatheter Artificial Heart Values Delivery System
NCT03788590 ·Status: UNKNOWN ·Phase: NA
-
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry
NCT07296016 ·Status: NOT_YET_RECRUITING
-
4D- Flow- MRI After Aortic Valve Surgery
NCT04223713 ·Status: UNKNOWN ·Phase: NA
-
TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium
NCT03600662 ·Status: RECRUITING ·Phase: NA
-
"Atriogenic Tricuspid Selected, Omics Profile, Multimodality Imaging and Clinical Outcomes"
NCT05724225 ·Status: UNKNOWN
-
Enhanced Valves Interventions and Safe AI Generated End Results
NCT07213531 ·Status: RECRUITING
-
NVT ALLEGRA TAVI System TF in Failing Surgical Aortic Bioprosthesis
NCT03287856 ·Status: COMPLETED ·Phase: NA
-
A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve
NCT05941455 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis
NCT07108478 ·Status: NOT_YET_RECRUITING
-
Multicenter Registry Study of Aortic Valve Stenosis in Zhejiang Elderly(Mrs AVS)
NCT03797820 ·Status: UNKNOWN
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
Safety and Feasibility of TRISKELE in Severe AS
NCT05391191 ·Status: UNKNOWN ·Phase: NA
-
The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NCT04204915 ·Status: RECRUITING ·Phase: NA
-
Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation
NCT05820516 ·Status: RECRUITING
-
Efficacy of Angiotensin Receptor Blocker Following aortIc Valve Intervention for Aortic STenOsis: a Randomized mulTi-cEntric Double-blind Phase II Study
NCT03315832 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Aortic Valve Replacement With Trifecta(TM)
NCT00475267 ·Status: COMPLETED ·Phase: NA
-
Observational Study of Prosthetic Tissue Aortic and Mitral Heart Valve
NCT00329667 ·Status: COMPLETED ·Phase: NA
-
Five-year Outcomes of Rapid-deployment Aortic Valve Replacement With the Edwards Intuity TM Valve
NCT04696926 ·Status: COMPLETED
-
Trifecta™ GT Post Market Clinical Follow-up
NCT03016169 ·Status: COMPLETED ·Phase: NA
-
TRanscAtheter TreatMent of PurE Aortic Regurgitation With VitaFlow Liberty System
NCT06818084 ·Status: RECRUITING ·Phase: PHASE4
-
The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis
NCT05847751 ·Status: ACTIVE_NOT_RECRUITING
-
Elimination of Microemboli During Aortic Valve Replacement
NCT01128751 ·Status: UNKNOWN ·Phase: NA